Zhongjin: Valuations of US stocks in the medical equipment sector have bottomed out.

The Zhongjin report stated that we have analyzed the stock price and performance of the medical device sector of the US stock market so far this year. We are optimistic about short-term recovery, with potential for large single products in the future. In the short to medium term, we believe that the weak stock prices of the medical device sector are diverging from solid fundamentals, and the sector's valuation has bottomed out. We see opportunities for short to medium term recovery in the medical device sector. In the long term, we believe that we still need to wait for the emergence of major breakthrough products. At present, we recommend focusing on high-growth subfields such as electrophysiology, structural heart disease, complex vascular intervention, surgical robots, and neuroscience.